Trutina Financial’s Novo Nordisk NVO Stock Holding History

Trutina Financial’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-480	Closed	-$11K	–	171
2014 Q1	$11K	Buy	+480	New	+$10.2K	0.01%	231

Other funds holding NVO

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Trutina Financial's NVO Position: Q2 2014 in Review

Trutina Financial sold out of Novo Nordisk (NVO) in Q2 2014, closing a stake of 480 shares — an estimated $11K sold.

Trutina Financial first reported a position in NVO in Q1 2014 and held it in 1 quarter. The position peaked at $11K in Q1 2014. 473 funds tracked by Wall St. Rank hold NVO as of Q2 2014.

Trutina Financial reported no remaining Novo Nordisk position as of Q2 2014 after selling out during the quarter.
Trutina Financial sold 480 Novo Nordisk shares in Q2 2014, an estimated $11K.
Trutina Financial first reported a position in Novo Nordisk in Q1 2014 and held it in 1 quarter.
Trutina Financial's Novo Nordisk position peaked at $11K in Q1 2014.
473 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2014.

Based on Trutina Financial's 13F filing for Q2 2014, filed 14 Aug 2014.